Pediatric Anesthesia — Airway Management, Equipment and Management

Image : “An Afghan child is prepared for anesthesia before undergoing a hydrocelectomy at Forward Operating Base Farah in Farah province, Afghanistan” by SrA Rylan K. Albright . License: Public Domain

Origin of Pediatric Anesthesia

Pediatric anesthesia as a subspecialty has come a long way. The humble origins can be traced back to 1842 when the rural physician Dr Crawford Long, rendered first documented ether anesthesia to an 8-year-old boy for a toe amputation.

Necessity is the mother of invention. The rise of pediatric surgery in the able hands of Dr Ladd, “the father of pediatric surgery” demanded a parallel development of refined pediatric anesthetic skills in Children’s Hospital of Boston.

Dr. Charles H. Robson from Toronto’s Hospital for Sick Children was the first pediatric anesthesiologist. His techniques of open-drop ether and cyclopropane administration, use of tracheal intubations in children in the 1930s fuelled pioneering research in pediatric anesthesia.

The golden era of pediatric anesthesia dates back to the 1980s and ‘90s.
The 21st century has witnessed the emergence of congenital cardiac anesthesia and pediatric pain medicine as subspecialties within pediatric anesthesia.

Airway of a Child

Pediatric patients are not little adults. They have unique anatomical differences from adults which necessitate customized care. The airway of a child is not a miniature replica of its adult counterpart. The differences can be summarized as follows:

All these factors culminate in increased airway resistance as per Poiseullie’s law, decreased residual lung volume, higher minute ventilation, and increased oxygen consumption. In children, the oxygen reserve is tenuous with underdeveloped respiratory drives.

All these factors have a bearing in pediatric mechanical ventilation and management of the airway.
Differences in other systems in the pediatric population, when compared to adults, are tabulated as below for easy recall:

Equipment for Pediatric Anesthesia

Airway devices for pediatric anesthesia have to be created specifically for children.

Endotracheal tubes (ETT)

The characteristics of endotracheal tubes specially designed for the pediatric population are as follows:

• Absence of cuff on the endotracheal tubes
• Smaller sized tubes

Size determination of endotracheal tubes:

• In neonates and infants, 3-4 size ETT suffices.
• For older children, the appropriate ETT size can be determined by the following formulae:
• For uncuffed ETT: Size = 4 + age/ 4
• For cuffed ETT: Size = 3.5 + age/ 4
• Another important factor is how deep the tube should be inserted to facilitate adequate ventilation.
• For cuffed tubes: Depth in cm = 3* internal diameter in mm

Laryngoscope

Image: “Infant laryngoscope with AA battery for size comparison.” by Erich Schulz, en:User:Erichgasboy – http://en.wikipedia.org/wiki/Image:Infant_laryngoscope.jpg. License: Public Domain

The modifications in laryngoscope to suit the pediatric community are as follows:

• The smaller size of blades and handle
• Prevalence of straight blades to deal with the short, stiff epiglottis
• Straight blades: Miller, Phillips, and Wis-Hipple
• Curved tubes are also available.

Fiberoptic laryngoscope has its own advantages. The examples include Bullard and Glide fiberoptic laryngoscopes.
Special devices have been built for children. They are as follows:

• Precordial stethoscope: for assessment of heart rate, heart tones, and respiratory quality
• Pre- and postductal pulse oximeter in neonates(a measurement of oximetry in either upper extremity and a lower extremity simultaneously).

State of the art technological advances in pediatric anesthesia include:

• Pulse oximetry-based hemoglobin determination
• Continuous cardiac output monitoring
• Anesthesia information management systems.

Other Considerations for Children

Anesthesiologist providing care to premature babies, children requiring cardiac surgery, neurosurgery, burn surgery, thoracic surgery or other specialized and high-risk procedures should have completed a pediatric anesthesia fellowship in addition to normal specialty training. Concerns in the pediatric population are unique. Some eminent ones are discussed below.

Temperature management in children

Temperature regulation in children is a very crucial aspect of pediatric anesthesia. Children are prone to hypothermia. Because of their relatively larger body surface in relation to their body mass, they lose heat much more rapidly than adults, hence it is very important to maintain normal body temperature in the OR and recovery room.

Few prominent reasons for this predisposition can be summarized as follows:

• Greater heat loss: thin skin, low-fat content, high surface area/weight ratio
• No shivering until 1 year
• Thermogenesis by brown fat
• More prone to iatrogenic hypo-/hyperthermia.

Temperature monitors are commonly used. Warmers ensure normothermia.

Fluid management in children

It is very easy to overload a child, so care with IV fluids and blood products is critical.
Based on the weight of the child, maintenance fluid can be estimated as follows:

• For 1st 0-10 kg: 4cc/kg/hr
• For next 10-20 kg: 2cc/kg/hr
• Above 20 kg: 1cc/kg/hr

The optimum maintenance fluids for children are D5LR, D5 with 1/2 NS and D5 with 1/4NS.
One must calculate the preoperative deficit and replace the same using the following protocol:

• In the first 1 hour: replace half of the deficit
• In next 1 hour: replace one quarter
• Replace the remaining one quarter in the third hour.

One must remember to add additional 2cc/kg/hr for minor surgeries. Additional maintenance fluid requirement can escalate up to 10 cc/kg/ hr in case of major surgeries. The same needs to be customized accordingly.

Blood loss in surgery is most of the times inevitable.

Pediatric anesthesia requires the calculation of approximate blood volume of the patient, subsequent estimated allowable loss and consequent calculation of replacement to be given.
The total blood volume in children can be estimated as follows:

Estimated allowable blood loss is calculated as:
Estimated allowable blood loss = Wt kg*estimated blood volume* (starting Hct- allowable Hct)/ avg Hct

In the pediatric population, blood loss replacement protocols are largely based on institutional practice and experience. A rough algorithm is as follows:

After initial replacement with 3*BSS or 1*colloid; blood products are used in the following formulations:

• Packed RBC: 10cc/kg
• Fresh frozen plasma (FFP): 10cc/kg
• Cryoprecipitate: 1U/10kg

Fluid overload in a child can manifest as pulmonary edema, circulatory overload and coagulation abnormalities. In certain circumstances, such as cardiothoracic surgeries, invasive monitoring is essential. It requires expertise and caution. Central venous line, with frequent cannulation of the IJV or femoral vein is used. The arterial line is most often cited in the right radial artery.

Pain management in children

Earlier beliefs that neonates cannot experience pain have been demolished. Pain management is of equal significance in the pediatric population when compared to adults. Pain management must be customized to the personality, size, and condition of the child.
The various modalities of pain management available for children are summarized as follows:

Perioperative concerns in children

Enhanced recovery protocol establishes optimal perioperative care in order to ensure better postoperative results. The salient features of perioperative care in pediatric anesthesia are mentioned below:

Preoperative measures: thorough history and physical examination form the keystone of successful patient care.

A special mention of any co-morbid illnesses; recent infections such as upper respiratory tract infection (URTI), however trivial, should be documented. Pre-operative workup should be elaborate enough to help the anesthetist anticipate any specific difficulties he is likely to encounter during the procedure.

Just adequate optimum starvation is advocated. A simple algorithm is as follows:

Separation anxiety is inevitable in children. The same can be alleviated with anxiolysis and premedications. Some ORs have the provision of a parental presence until induction.
Needle phobia is common in children, so inhalation induction is more common.

Intravenous access is challenging secondary to the presence of small veins and subcutaneous fat. Multiple sticks are discouraged.

Risk of laryngospasm

Children often develop laryngospasm when recovering from anesthesia.

Viral infection in the preceding 2-4 weeks of general anesthesia increases the risk 5 times. It involves involuntary spasm of laryngeal musculature often secondary to superior laryngeal nerve stimulation. Recent URTI, tobacco exposure and extubation attempts when lightly anesthetized predispose a patient to laryngospasm.

Treatment options

• Positive pressure ventilation
• Laryngospasm notch
• Propofol: 0.5-1 mg/kg/iv
• Succinycholine 2-4 mg/kg im.

Drug management in children

Immature and underdeveloped drug scavenging systems in the pediatric population predispose them to adverse effects secondary to the use of anesthetic agents.
Children generally require larger doses of induction drugs and maintenance drug compared to adults. Meticulous calculation of drug dosages is obligatory. In emergent circumstances, one can estimate the weight of a child using the following formulation:

Weight (estimate) = 2*age + 9

Inhalation induction is rapid and blood pressure of neonates and infants is more sensitive to hemodynamic effects of volatile agents. Of record, opioids are more potent in neonates with escalated sensitivity to respiratory centers. Neuromuscular blockers demonstrate shorter circulation time.

One must exercise caution against overdose. Two important anesthesia drug-related etiologies mainly prevalent in the pediatric community are:

Propofol infusion syndrome is more prevalent in the pediatric population. It can occur following 90 mcg/kg/min administration for as short as 8 hours. Manifestations include:

• Hemodynamic instability
• Hepatomegaly
• Metabolic acidosis
• Rhabdomyolysis
• Multiorgan failure.
• Emergent detection and treatment are essential to prevent untoward consequences.

Malignant hyperthermia is characterized by an acute hypermetabolic state in muscle tissue. The incidence of malignant hyperthermia in the pediatric population is estimated to be approximately 1:15,000 as opposed to 1:40,000 in adults. Familial predisposition and increased incidence in certain syndromes like muscular dystrophies exist. Succinylcholine and volatile agents are often triggering factors.

Manifestations include tachycardia, hyperkalemia, and dysrhythmias. The specific sign is the rapid rise in EtCO2. Contrary to the expectations, a rapid increase in temperature is rather a late sign.

Treatment options comprise of immediate discontinuation of the triggering agents, Dantrolene administration, cooling the patient and supportive symptomatic treatment as needed.

Summary

Pediatric anesthesia has come a long way since its inception. Children, not being the same as adults, need to be modified attention and care in accordance with their physiological makeup, needs, and pathologies.

The airway of a child is not the same as in an adult. The intricate differences have to be kept in mind while managing a pediatric patient.

Necessity encourages invention. The armamentarium of a pediatric anesthetist is well equipped with technologically sound, well-formulated and customized devices to satisfy the specific unique demands of the pediatric population.

Temperature regulation, drug management, fluid management, pain management, perioperative concerns are other important factors considered in children.